LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity.
暂无分享,去创建一个
A. Cazenave-Gassiot | M. Wenk | M. Hellerstein | H. Ingraham | A. Stahl | Edna Nyangau | D. Silver | W. C. Krause | M. Suzawa | M. Fitch | Diego A. Miranda | Hazel A Escusa | Juat Chin Foo | Diyala S. Shihadih | J. Foo | W. Krause | Diyala Shihadih
[1] T. Lüscher,et al. Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease , 2017, The Journal of clinical investigation.
[2] J. Borlak,et al. Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis. , 2016, Translational research : the journal of laboratory and clinical medicine.
[3] R. Coleman,et al. SEIPIN Regulates Lipid Droplet Expansion and Adipocyte Development by Modulating the Activity of Glycerol-3-phosphate Acyltransferase , 2016, Cell reports.
[4] P. Griffin,et al. Crystal Structures of the Nuclear Receptor, Liver Receptor Homolog 1, Bound to Synthetic Agonists*♦ , 2016, The Journal of Biological Chemistry.
[5] E. Gratton,et al. Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet. , 2016, Cell metabolism.
[6] J. Maher,et al. Isocaloric manipulation of macronutrients within a high-carbohydrate/moderate-fat diet induces unique effects on hepatic lipogenesis, steatosis and liver injury. , 2016, The Journal of nutritional biochemistry.
[7] B. Staels,et al. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease. , 2016, Annual review of physiology.
[8] J. Borén,et al. Liver receptor homolog‐1 is a critical determinant of methyl‐pool metabolism , 2016, Hepatology.
[9] A. Deacon,et al. Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocket. , 2015, Journal of structural biology.
[10] R. Fletterick,et al. A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver , 2015, eLife.
[11] A. Burt,et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. , 2015, Journal of hepatology.
[12] H. Kiyonari,et al. Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport , 2015, eLife.
[13] E. Gratton,et al. Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion , 2015, eLife.
[14] Richard P. Bazinet,et al. Polyunsaturated fatty acids and their metabolites in brain function and disease , 2014, Nature Reviews Neuroscience.
[15] A. Deacon,et al. The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1 , 2014, Proceedings of the National Academy of Sciences.
[16] E. Vassilatou. Nonalcoholic fatty liver disease and polycystic ovary syndrome. , 2014, World journal of gastroenterology.
[17] W. Martinet,et al. Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue. , 2014, World journal of gastroenterology.
[18] D. Silver,et al. Recent advances in understanding proteins involved in lipid droplet formation, growth and fusion. , 2014, Journal of genetics and genomics = Yi chuan xue bao.
[19] P. Edwards,et al. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. , 2013, Cell metabolism.
[20] D. Silver,et al. The Lipid Droplet as a Potential Therapeutic Target in NAFLD , 2013, Seminars in Liver Disease.
[21] P. Bedossa,et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. , 2013, Journal of hepatology.
[22] P. Griffin,et al. Divergent Sequence Tunes Ligand Sensitivity in Phospholipid-regulated Hormone Receptors* , 2013, The Journal of Biological Chemistry.
[23] Robert V Farese,et al. Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. , 2013, Developmental cell.
[24] Jonathan C. Cohen,et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. , 2012, The Journal of clinical investigation.
[25] Zhong-hai Yan,et al. Human thyroxine binding globulin (TBG) promoter directs efficient and sustaining transgene expression in liver-specific pattern. , 2012, Gene.
[26] J. Auwerx,et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver. , 2012, The Journal of clinical investigation.
[27] P. Li,et al. Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites , 2011, The Journal of cell biology.
[28] Robert V Farese,et al. Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase. , 2011, Cell metabolism.
[29] Scott A. Busby,et al. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects , 2011, Nature.
[30] Richard J Whitby,et al. Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2). , 2011, Journal of medicinal chemistry.
[31] D. Vance,et al. Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis , 2010, Hepatology.
[32] J. R. Prigge,et al. Cre activity in fetal albCre mouse hepatocytes: Utility for developmental studies , 2009, Genesis.
[33] Takao Shimizu,et al. Acyl-CoA:Lysophospholipid Acyltransferases* , 2009, Journal of Biological Chemistry.
[34] S. Kliewer,et al. Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. , 2008, Molecular endocrinology.
[35] Takao Shimizu,et al. Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity , 2008, Proceedings of the National Academy of Sciences.
[36] R. Wade,et al. Hypermethylation of Fads2 and Altered Hepatic Fatty Acid and Phospholipid Metabolism in Mice with Hyperhomocysteinemia* , 2007, Journal of Biological Chemistry.
[37] Shelly C. Lu,et al. Loss of the glycine N‐methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice , 2007, Hepatology.
[38] Michelle M Wiest,et al. A lipidomic analysis of nonalcoholic fatty liver disease , 2007, Hepatology.
[39] J. Auwerx,et al. Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1 , 2007, Molecular and Cellular Biology.
[40] Janet Hager,et al. Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP , 2005, Nature Structural &Molecular Biology.
[41] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[42] R. Hammer,et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[43] T. Willson,et al. Structural Analyses Reveal Phosphatidyl Inositols as Ligands for the NR5 Orphan Receptors SF-1 and LRH-1 , 2005, Cell.
[44] Jay D. Horton,et al. Post-transcriptional Regulation of Low Density Lipoprotein Receptor Protein by Proprotein Convertase Subtilisin/Kexin Type 9a in Mouse Liver* , 2004, Journal of Biological Chemistry.
[45] J. Breslow,et al. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[46] N. Wolins,et al. Adipocyte Protein S3-12 Coats Nascent Lipid Droplets* , 2003, Journal of Biological Chemistry.
[47] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[48] G. Gil,et al. Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha -hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription. , 2000, The Journal of biological chemistry.
[49] Richard D. Gregg,et al. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Hellerstein,et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. , 1991, The Journal of clinical investigation.
[51] R. Fletterick,et al. Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands. , 2009, Molecular endocrinology.
[52] D. L. Cinti,et al. The fatty acid chain elongation system of mammalian endoplasmic reticulum. , 1992, Progress in lipid research.